RB Restricts DNA Damage-Initiated Tumorigenesis through an LXCXE-Dependent Mechanism of Transcriptional Control

Molecular Cell

Volumn 43, Issue 4, 2011, Pages 663-672

  Bourgo, Ryan J ^a   Thangavel, Chellappagounder ^a   Ertel, Adam ^a   Bergseid, Jacqueline ^b   Kathleen McClendon, A ^a   Wilkens, Ludwig ^c   Witkiewicz, Agnieszka K ^a   Wang, Jean Y J ^b   Knudsen, Erik S ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c NORDSTADT HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LEUCYLCYSTYLGLUTAMIC ACID; POLYPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE; CONTROLLED STUDY; DNA DAMAGE; GENE EXPRESSION; GENOTOXICITY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BINDING;

AMINO ACID MOTIFS; ANIMALS; BINDING SITES; CELL LINE; CHROMATIN; DNA DAMAGE; GENE EXPRESSION REGULATION; HUMANS; MICE; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; RETINOBLASTOMA PROTEIN; TRANSCRIPTION, GENETIC;

EID: 80051748549     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2011.06.029     Document Type: Article

References (31)

1. Balsitis S., Dick F., Lee D., Farrell L., Hyde R.K., Griep A.E., Dyson N., Lambert P.F. Examination of the pRb-dependent and pRb-independent functions of E7 in vivo. J. Virol. 2005, 79:11392-11402.
2. Blais A., Dynlacht B.D. E2F-associated chromatin modifiers and cell cycle control. Curr. Opin. Cell Biol. 2007, 19:658-662.
3. Bourgo R.J., Ehmer U., Sage J., Knudsen E.S. RB deletion disrupts coordination between DNA replication licensing and mitotic entry in vivo. Mol. Biol. Cell 2011, 22:931-939.
4. Burkhart D.L., Sage J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat. Rev. Cancer 2008, 8:671-682.
5. Chen T.T., Wang J.Y. Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function. Mol. Cell. Biol. 2000, 20:5571-5580.
6. Coschi C.H., Martens A.L., Ritchie K., Francis S.M., Chakrabarti S., Berube N.G., Dick F.A. Mitotic chromosome condensation mediated by the retinoblastoma protein is tumor-suppressive. Genes Dev. 2010, 24:1351-1363.
7. Dick F.A., Sailhamer E., Dyson N.J. Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins. Mol. Cell. Biol. 2000, 20:3715-3727.
8. Ertel A., Dean J.L., Rui H., Liu C., Witkiewicz A.K., Knudsen K.E., Knudsen E.S. RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response. Cell Cycle 2010, 9:4153-4163.
9. Francis S.M., Bergsied J., Isaac C.E., Coschi C.H., Martens A.L., Hojilla C.V., Chakrabarti S., Dimattia G.E., Khoka R., Wang J.Y., Dick F.A. A functional connection between pRB and transforming growth factor beta in growth inhibition and mammary gland development. Mol. Cell. Biol. 2009, 29:4455-4466.
10. Francis S.M., Chakrabarti S., Dick F.A. A context-specific role for retinoblastoma protein-dependent negative growth control in suppressing mammary tumorigenesis. PLoS ONE 2011, 6:e16434.
11. Harrington E.A., Bruce J.L., Harlow E., Dyson N. pRB plays an essential role in cell cycle arrest induced by DNA damage. Proc. Natl. Acad. Sci. USA 1998, 95:11945-11950.
12. Henley S.A., Francis S.M., Demone J., Ainsworth P., Dick F.A. A cancer derived mutation in the retinoblastoma gene with a distinct defect for LXCXE dependent interactions. Cancer Cell Int. 2010, 10:8.
13. Herrera R.E., Sah V.P., Williams B.O., Mäkelä T.P., Weinberg R.A., Jacks T. Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol. 1996, 16:2402-2407.
14. Isaac C.E., Francis S.M., Martens A.L., Julian L.M., Seifried L.A., Erdmann N., Binné U.K., Harrington L., Sicinski P., Bérubé N.G., et al. The retinoblastoma protein regulates pericentric heterochromatin. Mol. Cell. Biol. 2006, 26:3659-3671.
15. Jacks T., Fazeli A., Schmitt E.M., Bronson R.T., Goodell M.A., Weinberg R.A. Effects of an Rb mutation in the mouse. Nature 1992, 359:295-300.
16. Kleinerman R.A., Tucker M.A., Tarone R.E., Abramson D.H., Seddon J.M., Stovall M., Li F.P., Fraumeni J.F. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J. Clin. Oncol. 2005, 23:2272-2279.
17. Knudsen E.S., Knudsen K.E. Tailoring to RB: tumour suppressor status and therapeutic response. Nat. Rev. Cancer 2008, 8:714-724.
18. Knudsen E.S., Wang J.Y. Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J. Biol. Chem. 1996, 271:8313-8320.
19. Knudsen E.S., Sexton C.R., Mayhew C.N. Role of the retinoblastoma tumor suppressor in the maintenance of genome integrity. Curr. Mol. Med. 2006, 6:749-757.
20. Lee J.O., Russo A.A., Pavletich N.P. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature 1998, 391:859-865.
21. Manning A.L., Longworth M.S., Dyson N.J. Loss of pRB causes centromere dysfunction and chromosomal instability. Genes Dev. 2010, 24:1364-1376.
22. Markey M.P., Angus S.P., Strobeck M.W., Williams S.L., Gunawardena R.W., Aronow B.J., Knudsen E.S. Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action. Cancer Res. 2002, 62:6587-6597.
23. Martinez L.A., Goluszko E., Chen H.Z., Leone G., Post S., Lozano G., Chen Z., Chauchereau A. E2F3 is a mediator of DNA damage-induced apoptosis. Mol. Cell. Biol. 2010, 30:524-536.
24. Mayhew C.N., Bosco E.E., Fox S.R., Okaya T., Tarapore P., Schwemberger S.J., Babcock G.F., Lentsch A.B., Fukasawa K., Knudsen E.S. Liver-specific pRB loss results in ectopic cell cycle entry and aberrant ploidy. Cancer Res. 2005, 65:4568-4577.
25. Mayhew C.N., Carter S.L., Fox S.R., Sexton C.R., Reed C.A., Srinivasan S.V., Liu X., Wikenheiser-Brokamp K., Boivin G.P., Lee J.S., et al. RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis. Gastroenterology 2007, 133:976-984.
26. Morris E.J., Dyson N.J. Retinoblastoma protein partners. Adv. Cancer Res. 2001, 82:1-54.
27. Nevins J.R. The Rb/E2F pathway and cancer. Hum. Mol. Genet. 2001, 10:699-703.
28. Rajewsky M.F., Dauber W., Frankenberg H. Liver carcinogenesis by diethylnitrosamine in the rat. Science 1966, 152:83-85.
29. Stengel K.R., Thangavel C., Solomon D.A., Angus S.P., Zheng Y., Knudsen E.S. Retinoblastoma/p107/p130 pocket proteins: protein dynamics and interactions with target gene promoters. J. Biol. Chem. 2009, 284:19265-19271.
30. Talluri S., Isaac C.E., Ahmad M., Henley S.A., Francis S.M., Martens A.L., Bremner R., Dick F.A.A. A G1 checkpoint mediated by the retinoblastoma protein that is dispensable in terminal differentiation but essential for senescence. Mol. Cell. Biol. 2010, 30:948-960.
31. Zhang H.S., Dean D.C. Rb-mediated chromatin structure regulation and transcriptional repression. Oncogene 2001, 20:3134-3138.